Back

Comparative analysis of the carbon footprint of biologics for severe asthma

2025-08-12 respiratory medicine Title + abstract only
View on medRxiv
Show abstract

ObjectiveTo quantify, compare, and analyse the cradle-to-gate carbon emissions of biologic treatments for severe asthma. DesignCradle-to-gate carbon emissions for six monoclonal antibody therapies were calculated using MCF Classifier. A representative patient, eligible for all therapies, was defined to enable comparisons. Sensitivity, scenario, and pairwise analyses were conducted to explore variation in emissions and opportunities for reduction. Outcome MeasuresThe primary outcome was first-y...

Predicted journal destinations